Bristol-Myers Squibb Company
Heteroarylhydroxypyrimidinones as agonists of the APJ receptor

Abstract:

The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments, in particular for treating cardiovascular disorders. ##STR00001##